Biotech RadarJobs updated

COMPANY

Tandem Diabetes

HQ: San Diego, CA source · tandemdiabetes.com ↗

Past trials only

45 open jobs · last seen Oct 23, 2026 · 19 sources

Location: San Diego, CA · source · Oct 12, 2026

Profile checked Oct 10, 2026

Keywords: Type 1 Diabetes Mellitus Type 1 Diabetes Type 2 Diabetes Treated With Insulin Diabetes Mellitus Type1diabetes Insulin Pump t:slim X2 insulin pump with Tandem Freedom Algorithm t:slim X2 insulin pump with Control-IQ technology 1.5 t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) Control-IQ Technology v1.5 SteadiSet Infusion Set Control-IQ technology 2.0 SteadiSet Extended Wear Infusion Set t:slim X2 insulin pump with Control-IQ technology 2.0 Automated Insulin Delivery Settings Initialization and Adaptation Algorithm Control-IQ technology 1.5 SIGI Insulin Management System Predictive Low Glucose Suspend t:slim X2 pump with Control-IQ technology t:slim insulin pump with predictive low glucose suspend

45Open jobs18Trials (company is sponsor)

Hiring

TitleLocation (from posting)Employer postedFirst seen
Sr. Quality Engineer I - Manufacturing / SterilizationCalifornia - BarnesOct 22, 2026Oct 5, 2026
Sr. Manager, Sales Excellence and Sales Training, International2 locations (listed on the posting)Oct 22, 2026Oct 14, 2026
Sr Quality Engineer I - ManufacturingCalifornia - BarnesOct 22, 2026Oct 23, 2026
Clinical Diabetes Sales Specialist PACAMarseille, FranceOct 22, 2026Oct 23, 2026
Distributor Operations SpecialistEindhoven, NetherlandsOct 21, 2026Oct 15, 2026

See all 45 jobs

Timeline

  1. Board tracked Radar started tracking this company’s job board (45 open jobs at last check). source ↗
  2. Trial start —: The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France source ↗
  3. Trial start Not phased (device or behavioral study): Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes source ↗
  4. Trial start Not phased (device or behavioral study): Tandem Freedom - Feasibility Trial 2 source ↗
  5. Trial start —: PS230005 Control-IQ 1.5 Post-Approval Study source ↗
  6. Trial start Not phased (device or behavioral study): Sigi Insulin Management System - A First-in-Human Study in Adults With Type 1 Diabetes source ↗
  7. Trial start Not phased (device or behavioral study): Tandem Freedom Feasibility Study 1 source ↗
  8. Trial start Not phased (device or behavioral study): Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes source ↗
  9. Trial start Not phased (device or behavioral study): A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes source ↗
  10. Trial start Not phased (device or behavioral study): Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes source ↗
  11. Trial start Not phased (device or behavioral study): Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes source ↗
  12. Trial start Not phased (device or behavioral study): Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ) source ↗
  13. Trial start Not phased (device or behavioral study): Adaptation of Insulin Delivery Settings to Improve Clinical Outcomes With AID Use source ↗
  14. Trial start Not phased (device or behavioral study): Control-IQ Technology in Individuals With Type 2 Diabetes source ↗
  15. Trial start Not phased (device or behavioral study): Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study source ↗
  16. Trial start —: Control-IQ Observational (CLIO) Post-Approval Study source ↗
  17. Trial start Not phased (device or behavioral study): Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial source ↗
  18. Trial start Phase 1: Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study source ↗
  19. Trial start —: Validation Study of G4 User Interface source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Open jobs 45

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
Sr. Quality Engineer I - Manufacturing / SterilizationCalifornia - BarnesOct 22, 2026Oct 5, 2026Senior
Sr. Manager, Sales Excellence and Sales Training, International2 locations (listed on the posting)Oct 22, 2026Oct 14, 2026Senior
Sr Quality Engineer I - ManufacturingCalifornia - BarnesOct 22, 2026Oct 23, 2026Not stated
Clinical Diabetes Sales Specialist PACAMarseille, FranceOct 22, 2026Oct 23, 2026Not stated
Distributor Operations SpecialistEindhoven, NetherlandsOct 21, 2026Oct 15, 2026Mid
Manager, Global VigilanceRemote USOct 20, 2026Oct 21, 2026Not stated
Territory Manager - Alabama SouthAlabama RemoteOct 19, 2026Oct 15, 2026Mid
Territory Manager - Ottawa/Kingston, Ontario2 locations, including Ontario, Canada RemoteOct 16, 2026Oct 7, 2026Mid
Revenue AccountantLausanne, SwitzerlandOct 16, 2026Oct 16, 2026Not stated
Territory Manager - Montreal SouthCanada Remote - QuebecOct 16, 2026Oct 16, 2026Not stated
Regional Account Manager - Great LakesRemote USOct 15, 2026Oct 16, 2026Not stated
Program Manager (R&D)California - BarnesOct 14, 2026Oct 7, 2026Mid
Sr. Corporate Counsel - ContractsRemote USOct 14, 2026Oct 15, 2026Senior
Clinical Diabetes Sales Specialist - Houston NorthTexas RemoteOct 14, 2026Oct 15, 2026Entry
Failure Investigation Technician IICalifornia - BarnesOct 13, 2026Oct 14, 2026Mid
Failure Investigation Technician ICalifornia - BarnesOct 13, 2026Oct 14, 2026Entry
Clinical Diabetes Sales Specialist - North AlbertaCanada Remote - AlbertaOct 13, 2026Oct 14, 2026Entry
Software Test Engineer ICalifornia - BarnesOct 12, 2026Oct 12, 2026Entry
Sr. Field Study Test Associate ICalifornia - High BluffOct 9, 2026Oct 9, 2026Senior
Sr. Supplier Quality Engineer IRemote - San Diego, CAOct 9, 2026Oct 10, 2026Senior
Sr. Product Manager, InternationalCalifornia - High BluffOct 8, 2026Oct 7, 2026Senior
Supervisor, Pump ProductionCalifornia - BarnesOct 6, 2026Oct 7, 2026Senior
Clinical Diabetes Sales Specialist (w/m/d)2 locations (listed on the posting)Oct 6, 2026Oct 6, 2026Mid
Insurance Specialist / Krankenkassen Spezialist (m/w/d)Frankfurt, GermanySep 29, 2026Oct 5, 2026Mid
Electrical Engineering Technician I/IICalifornia - High BluffSep 24, 2026Oct 5, 2026Mid
Clinical Diabetes Sales Specialist - Central MissouriMissouri RemoteSep 23, 2026Oct 5, 2026Entry
Freelancer /Freiberufler (m/w/d) für Schulungen von InsulinpumpenGermany RemoteSep 23, 2026Oct 5, 2026Mid
Principal Site Reliability EngineerRemote USSep 23, 2026Oct 5, 2026Senior
Reliability Engineering Technician I (Temp to Hire)California - BarnesSep 23, 2026Oct 5, 2026Entry
Senior Digital Marketing Manager (Omnichannel/Paid Media)California RemoteSep 23, 2026Oct 5, 2026Senior
Director, BenefitsRemote USSep 23, 2026Oct 5, 2026Senior
Sr. Marketing Technology StrategistCalifornia RemoteSep 23, 2026Oct 5, 2026Senior
Clinical Diabetes Sales Specialist - Fort Myers, FLFlorida RemoteSep 23, 2026Oct 5, 2026Entry
Director, Product Marketing; Integrated SystemsCalifornia - High BluffSep 23, 2026Oct 5, 2026Senior
Sr Software Test Engineer I (Pump Software)California - High BluffSep 23, 2026Oct 5, 2026Senior
Sr. Project Manager (R&D)California - High BluffSep 23, 2026Oct 7, 2026Senior
Sr Mobile Infrastructure Engineer IIRemote USSep 23, 2026Oct 7, 2026Senior
Clinical Diabetes Sales Specialist, Memphis TennesseeTennessee RemoteSep 23, 2026Oct 7, 2026Entry
Sr Software Test Engineer ICalifornia - BarnesSep 23, 2026Oct 7, 2026Senior
Facilities Technician ICalifornia - High BluffSep 23, 2026Oct 7, 2026Entry
Sr. Software Engineer II - Embedded C Build Systems and ToolsCalifornia RemoteSep 23, 2026Oct 7, 2026Senior
Clinical Diabetes Sales SpecialistBelgium RemoteSep 23, 2026Oct 7, 2026Entry
Quality Control Inspector II (3-Month Contract)California - CapBio IrvineSep 23, 2026Oct 7, 2026Mid
Manufacturing Engineering Technician II (3 Month Contract)California - MarindustrySep 23, 2026Oct 7, 2026Mid
Contract Clinical Diabetes Specialist - Ottawa/Kingston, Ontario2 locations, including Ontario, Canada RemoteSep 22, 2026Oct 5, 2026Entry

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Clinical trials (lead sponsor) 18

RecordTitlePhaseStatusStartPrimary completion
NCT07211126The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in FranceNot listedRecruitingMar 3, 20262027-12 (estimated)
NCT06717451PS230005 Control-IQ 1.5 Post-Approval StudyNot listedCompletedJan 30, 2025Aug 10, 2026 (actual)
NCT07325461Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 DiabetesNot phased (device or behavioral study)CompletedFeb 18, 2026Jun 24, 2026 (actual)
NCT05014789Control-IQ Technology 2.0 Adult and Adolescent Feasibility StudyNot phased (device or behavioral study)CompletedAug 19, 2021Dec 20, 2021 (actual)
NCT05785832A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 DiabetesNot phased (device or behavioral study)CompletedJun 1, 2023Sep 24, 2024 (actual)
NCT06834568Tandem Freedom - Feasibility Trial 2Not phased (device or behavioral study)CompletedMar 24, 2025Apr 7, 2025 (actual)
NCT06428591Tandem Freedom Feasibility Study 1Not phased (device or behavioral study)CompletedMay 29, 2024Jun 10, 2024 (actual)
NCT06273124Investigational Extended Wear Insulin Infusion Set in People With Type 1 DiabetesNot phased (device or behavioral study)CompletedMar 7, 2024Dec 11, 2024 (actual)
NCT05422053Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ)Not phased (device or behavioral study)CompletedJun 29, 2022Jan 6, 2023 (actual)
NCT05683392Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 DiabetesNot phased (device or behavioral study)CompletedFeb 1, 2023Dec 13, 2023 (actual)
NCT05403502Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 DiabetesNot phased (device or behavioral study)CompletedAug 31, 2022Aug 2, 2023 (actual)
NCT05204134Adaptation of Insulin Delivery Settings to Improve Clinical Outcomes With AID UseNot phased (device or behavioral study)CompletedMar 24, 2022Sep 9, 2022 (actual)
NCT05111301Control-IQ Technology in Individuals With Type 2 DiabetesNot phased (device or behavioral study)CompletedNov 30, 2021Aug 10, 2022 (actual)
NCT05973422Sigi Insulin Management System - A First-in-Human Study in Adults With Type 1 DiabetesNot phased (device or behavioral study)Unknown status (ClinicalTrials.gov)May 31, 2024Sep 30, 2024 (estimated)
NCT03195140Diabetes Pump With Predictive Low Glucose Suspend Pivotal TrialNot phased (device or behavioral study)CompletedAug 11, 2017Feb 6, 2018 (actual)
NCT04503174Control-IQ Observational (CLIO) Post-Approval StudyNot listedCompletedAug 4, 2020Jun 2, 2023 (actual)
NCT02877771Tandem Predictive Low Glucose Suspend Inpatient Feasibility StudyPhase 1Completed2016-082016-08 (actual)
NCT01142895Validation Study of G4 User InterfaceNot listedCompleted2010-052010-05 (actual)
Feedback